Testing effectiveness (Phase 2)Study completedNCT00724048
What this trial is testing
Pridopidine (ACR16) for the Treatment of Participants With Huntington's Disease
Who this might be right for
Huntington Disease
Teva Branded Pharmaceutical Products R&D, Inc. 227